Disrupting the clustering of GABAA receptor  2 subunits in the frontal cortex leads to reduced  -power and cognitive deficits

Enhanced Tonic Inhibition Influences the Hypnotic and Amnestic Actions of the Intravenous Anesthetics Etomidate and Propofol

(2013) K. Kretschmannova et al.   JOURNAL OF NEUROSCIENCE

Cortical Glutamic Acid Decarboxylase 67 Deficiency Results in Lower Cannabinoid 1 Receptor Messenger RNA Expression: Implications for Schizophrenia

(2011) Stephen M. Eggan et al.   BIOLOGICAL PSYCHIATRY

Gephyrin-mediated γ-Aminobutyric Acid Type A and Glycine Receptor Clustering Relies on a Common Binding Site

(2011) Hans-Michael Maric et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The Residence Time of GABAARs at Inhibitory Synapses Is Determined by Direct Binding of the Receptor  1 Subunit to Gephyrin

(2011) J. Mukherjee et al.   JOURNAL OF NEUROSCIENCE

Gamma synchrony: Towards a translational biomarker for the treatment-resistant symptoms of schizophrenia

(2011) Michael J. Gandal et al.   NEUROPHARMACOLOGY

The role of serotonin in the NMDA receptor antagonist models of psychosis and cognitive impairment

(2011) Herbert Y. Meltzer et al.   PSYCHOPHARMACOLOGY

Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia

(2011) David A. Lewis et al.   TRENDS IN NEUROSCIENCES

Exploring intermediate phenotypes with EEG: Working memory dysfunction in schizophrenia

(2010) Corinna Haenschel et al.   BEHAVIOURAL BRAIN RESEARCH

A Randomized Clinical Trial of MK-0777 for the Treatment of Cognitive Impairments in People with Schizophrenia

(2010) Robert W. Buchanan et al.   BIOLOGICAL PSYCHIATRY

Reducing Prefrontal Gamma-Aminobutyric Acid Activity Induces Cognitive, Behavioral, and Dopaminergic Abnormalities That Resemble Schizophrenia

(2010) Takeshi Enomoto et al.   BIOLOGICAL PSYCHIATRY

Lamina-Specific Alterations in Cortical GABAA Receptor Subunit Expression in Schizophrenia

(2010) Monica Beneyto et al.   CEREBRAL CORTEX

Complex Role of Collybistin and Gephyrin in GABAAReceptor Clustering

(2010) Leila Saiepour et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Animal models of neuropsychiatric disorders

(2010) Eric J Nestler et al.   NATURE NEUROSCIENCE

Pharmacological Enhancement of Memory and Executive Functioning in Laboratory Animals

(2010) Stan B Floresco et al.   NEUROPSYCHOPHARMACOLOGY

Assessment of NMDA receptor NR1 subunit hypofunction in mice as a model for schizophrenia

(2009) T. B. Halene et al.   GENES BRAIN AND BEHAVIOR

Parvalbumin neurons and gamma rhythms enhance cortical circuit performance

(2009) Vikaas S. Sohal et al.   NATURE

Driving fast-spiking cells induces gamma rhythm and controls sensory responses

(2009) Jessica A. Cardin et al.   NATURE

Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes

(2009) Juan E Belforte et al.   NATURE NEUROSCIENCE

Mouse neurexin-1  deletion causes correlated electrophysiological and behavioral changes consistent with cognitive impairments

(2009) M. R. Etherton et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Subunit-Selective Modulation of GABA Type A Receptor Neurotransmission and Cognition in Schizophrenia

(2008) David A. Lewis et al.   AMERICAN JOURNAL OF PSYCHIATRY

Synaptic Imbalance, Stereotypies, and Impaired Social Interactions in Mice with Altered Neuroligin 2 Expression

(2008) R. M. Hines et al.   JOURNAL OF NEUROSCIENCE

The Clustering of GABAA Receptor Subtypes at Inhibitory Synapses is Facilitated via the Direct Binding of Receptor  2 Subunits to Gephyrin

(2008) V. Tretter et al.   JOURNAL OF NEUROSCIENCE

Tiagabine Increases [11C]flumazenil Binding in Cortical Brain Regions in Healthy Control Subjects

(2008) W Gordon Frankle et al.   NEUROPSYCHOPHARMACOLOGY

Realistic expectations of prepulse inhibition in translational models for schizophrenia research

(2008) Neal R. Swerdlow et al.   PSYCHOPHARMACOLOGY